Ji, Xianyou
Xia, Jinlan
Zhang, Hong
Ren, Changjie
Ma, Guang
Fu, Shenwen
Zhang, Jun
Chen, Ying
Han, Xuebin
Zhang, Jianming
Fang, Zhengxu
Yang, Bo
Yang, Baisong
Huang, Wenjun
Yin, Gang
Qi, Hong
Gong, Hao
Wang, Dongfang
Hao, Liuyi
Zhao, Xiufeng
Pei, Zhaohui
Wang, Peijian
Li, Xiaodong
Lin, Ling
Li, De
Li, Zhi
Zhang, Lin
Yin, Bo
Cheng, Ying
You, Zhiqing
Sheng, Jianlong
Wu, Jie
Chen, Ling
Fan, Zhongcai
Zhao, Wang
Zhao, Shuiping
Article History
Received: 15 April 2025
Accepted: 11 July 2025
First Online: 22 July 2025
Declarations
:
: The study had the approval of the Ethics Committee at each center, with the principal center being Xiangya Second Hospital of Central South University. The ethics approval number provided by the Ethics Committee of Xiangya Second Hospital of Central South University was 2021K191. This study was registered on the Drug Clinical Trial Registration and Information Disclosure Platform with the registration number of CTR20213031.
: Not applicable.
: The authors declare no competing interests.